Medpace CEO sells 10,880 shares at $620 avg
Medpace’s CEO and major shareholder August J. Troendle sold 10,880 shares while retaining substantial direct and indirect holdings.
Rhea-AI Filing Summary
Medpace Holdings, Inc. (MEDP) reported that President & CEO and ten percent owner August J. Troendle sold 10,880 shares of Common Stock on September 17, 2026 in an open-market sale at a weighted average price of $620.40 per share, effected pursuant to a limit order during an open window period.
After this transaction, Troendle directly held 504,273 shares of Medpace common stock and also had indirect ownership of 4,733,019 shares held by Medpace Investors, LLC, over which he has sole voting and investment control while disclaiming beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 10,880 shares
Net Sell
2 txns
Insider
Troendle August J.
Role
President & CEO
Sold
10,880 shs ($6.75M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 10,880 | $620.40 | $6.75M |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 504,273 shares (Direct);
Common Stock — 4,733,019 shares (Indirect, By Medpace Investors, LLC)
Footnotes (3)
- F1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- F2. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $622.21. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F3. The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Shares sold: 10,880 shares
Weighted average sale price: $620.40 per share
Direct holdings after transaction: 504,273 shares
+2 more
5 metrics
Shares sold
10,880 shares
Common Stock sold by August J. Troendle on September 17, 2026
Weighted average sale price
$620.40 per share
Open-market sale on September 17, 2026; transactions ranged from $620.00 to $622.21
Direct holdings after transaction
504,273 shares
Common Stock directly owned by August J. Troendle after the reported sale
Indirect holdings through Medpace Investors, LLC
4,733,019 shares
Common Stock held indirectly with sole voting and investment control, subject to beneficial ownership disclaimer
Reported sell transactions
1 sale
Single non-derivative sale transaction reported on this Form 4
Key Terms
limit order, weighted average price, indirectly beneficially own, pecuniary interest, +1 more
5 terms
limit order market
"transactions were effected pursuant to a limit order placed by the Reporting Person"
A limit order is an instruction to buy or sell a stock only at a specific price or better, giving you control over the exact price you pay or receive. It matters to investors because it acts like a price guard—similar to setting a maximum you’ll pay for an item at a store—so you avoid unexpected prices, though the trade may not happen if the market never reaches your limit.
weighted average price financial
"The reported price is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
indirectly beneficially own regulatory
"may be deemed to indirectly beneficially own the securities of the Issuer"
pecuniary interest regulatory
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest"
voting and investment control financial
"has sole voting and investment control with respect to the securities held"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MEDP report for August J. Troendle on this Form 4?
August J. Troendle reported a sale of 10,880 shares of Medpace Holdings, Inc. Common Stock on September 17, 2026 in an open-market transaction at a weighted average price of $620.40 per share, executed pursuant to a limit order during an open window period.
What indirect MEDP holdings are associated with Medpace Investors, LLC?
The filing reports 4,733,019 shares of Medpace Common Stock held indirectly by August J. Troendle through Medpace Investors, LLC, where he is the sole manager and controlling unit holder with sole voting and investment control over those securities.
Was the MEDP insider sale made under a Rule 10b5-1 trading plan?
The document-level Rule 10b5-1 checkbox is not affirmed, and a footnote explains the trades were executed pursuant to a limit order placed during an open window period, without stating that they were made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
